Stifel Financial
AGTC

Stifel Financial’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Stifel Financial’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-90,269
Closed -$25K – 3424
2022
Q3 		$25K Buy
90,269
+9,500
+12% +$4.15K ﹤0.01% 3223
2022
Q2 		$62K Buy
80,769
+64,200
+387% +$57.2K ﹤0.01% 3210
2022
Q1 		$18K Hold
16,569
– – ﹤0.01% 3346
2021
Q4 		$31K Sell
16,569
-34,110
-67% -$81.7K ﹤0.01% 3333
2021
Q3 		$152K Sell
50,679
-34,890
-41% -$124K ﹤0.01% 3184
2021
Q2 		$335K Buy
85,569
+40,250
+89% +$167K ﹤0.01% 2830
2021
Q1 		$230K Buy
45,319
+5,744
+15% +$29.8K ﹤0.01% 2942
2020
Q4 		$162K Buy
+39,575
New +$194K ﹤0.01% 2866

Stifel Financial's AGTC Position: Q4 2022 in Review

Stifel Financial sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 90,269 shares — an estimated $25K sold.

Stifel Financial first reported a position in AGTC in Q4 2020 and held it in 8 quarters. The position peaked at $335K in Q2 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

  • Stifel Financial reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
  • Stifel Financial sold 90,269 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $25K.
  • Stifel Financial first reported a position in Applied Genetic Technologies Corporation in Q4 2020 and held it in 8 quarters.
  • Stifel Financial's Applied Genetic Technologies Corporation position peaked at $335K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Stifel Financial's 13F filing for Q4 2022, filed 13 Feb 2023.